Back to Search Start Over

Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study

Authors :
Bente Glintborg
Philip J. Mease
Christine Ballegaard
Lone Skov
Lene Dreyer
Pil Højgaard
Lars Erik Kristensen
Kirstine Amris
Jørgen Guldberg-Møller
Else Marie Bartels
Henning Bliddal
Robin Christensen
Sabrina Mai Nielsen
Maarten de Wit
Karen Ellegaard
Source :
Højgaard, P, Ellegaard, K, Nielsen, S M, Christensen, R, Guldberg-Møller, J, Ballegaard, C, Dreyer, L, Mease, P, de Wit, M, Skov, L, Glintborg, B, Bliddal, H, Bartels, E M, Amris, K & Kristensen, L E 2019, ' Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis : A prospective cohort study ', Arthritis Care & Research, vol. 71, no. 6, pp. 798-810 . https://doi.org/10.1002/acr.23693, Højgaard, P, Ellegaard, K, Nielsen, S M, Christensen, R, Guldberg-Møller, J, Ballegaard, C, Dreyer, L, Mease, P, de Wit, M, Skov, L, Glintborg, B, Bliddal, H, Bartels, E M, Amris, K & Kristensen, L E 2019, ' Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis : A Prospective Cohort Study ', Arthritis Care & Research, vol. 71, no. 6, pp. 798-810 . https://doi.org/10.1002/acr.23693
Publication Year :
2019
Publisher :
Wiley, 2019.

Abstract

OBJECTIVE: To study the prognostic value of widespread pain and of musculoskeletal ultrasound (US) examination for subsequent treatment outcomes in patients with psoriatic arthritis (PsA).METHODS: An exploratory prospective cohort study enrolled patients with PsA initiating biologic or conventional synthetic disease-modifying antirheumatic drugs in routine care. Clinical, US, and patient-reported measures were collected at baseline and after 4 months. Widespread nonarthritic pain (WP) was defined as a Widespread Pain Index score of ≥4 with pain in ≥4 of 5 regions. PsA activity by US was defined as color Doppler (yes/no) in selected entheses, joints, or tendons. The main response criteria included the American College of Rheumatology 20% improvement, the Disease Activity in Psoriatic Arthritis 50% improvement, and minimal disease activity. The primary analyses were age- and sex-adjusted logistic regression.RESULTS: WP was present in 24 of 69 included patients (35%) and was associated with worse patient-reported and composite baseline measures, while US and other objective findings were similar to those in patients without WP. The odds of reaching minimal disease activity after 4 months were significantly greater for patients enrolled without WP (odds ratio 18.43 [95% confidence interval 1.51, 224.41]; P = 0.022), while WP did not impair other response measures. Patients with baseline color Doppler activity (n = 42 [61%]) had a worse objective PsA burden, but their chance of treatment response was comparable to those without color Doppler.CONCLUSION: More than one-third of patients with PsA presented with WP, which was associated with worse patient-reported scores and failure to achieve minimal disease activity following conventional synthetic or biologic disease-modifying antirheumatic drug therapy. PsA activity by color Doppler US had no influence on subsequent treatment response in this PsA cohort.

Details

ISSN :
21514658 and 2151464X
Volume :
71
Database :
OpenAIRE
Journal :
Arthritis Care & Research
Accession number :
edsair.doi.dedup.....54868589dedfb1e9deaf6be966337e30
Full Text :
https://doi.org/10.1002/acr.23693